Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.
Verpalen VA, Coerkamp CF, Hinderks MJ, Meeder JG, Winter MM, Arkenbout EK, Vis JC, Habets J, Smulders MW, Mihl C, van Ofwegen-Hanekamp CEE, van der Spoel TIG, Tanis W, van Gelder RE, van der Wielen MLJ, Somsen GA, Kikkert WJ, Carati LF, El Barzouhi A, van Bergen PFMM, Dedic A, Prokop M, Stallmann HP, Beele XDY, Quarles van Ufford HME, Nijveldt R, Dijkgraaf MGW, Damman P, Planken RN, Henriques JPS; CLEAR-CAD investigators. Verpalen VA, et al. Among authors: arkenbout ek. Neth Heart J. 2024 Nov;32(11):387-396. doi: 10.1007/s12471-024-01906-3. Epub 2024 Oct 18. Neth Heart J. 2024. PMID: 39422833 Free PMC article.
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study.
van der Sangen NMR, Küçük IT, Sivanesan S, Appelman Y, Ten Berg JM, Verburg A, Azzahhafi J, Arkenbout EK, Kikkert WJ, Pisters R, Jukema JW, Arslan F, van 't Hof A, Ilhan M, Hoebers LP, van der Schaaf RJ, Damman P, Woudstra P, van de Hoef TP, Bax M, Anthonio RL, Polad J, Adriaenssens T, Dewilde W, Zivelonghi C, Laanmets P, Majas R, Dijkgraaf MGW, Claessen BEPM, Henriques JPS. van der Sangen NMR, et al. Among authors: arkenbout ek. Am Heart J. 2023 Nov;265:114-120. doi: 10.1016/j.ahj.2023.07.011. Epub 2023 Jul 28. Am Heart J. 2023. PMID: 37517430 Free article. Clinical Trial.
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.
Kerkmeijer LSM, Renkens MPL, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Garcia-Garcia HM, Kraak R, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: arkenbout ek. EuroIntervention. 2022 Mar 18;17(16):1340-1347. doi: 10.4244/EIJ-D-21-00419. EuroIntervention. 2022. PMID: 34483094 Free PMC article. Clinical Trial.
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
Kerkmeijer LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Kraak RP, Onuma Y, Serruys PW, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: arkenbout ek. Catheter Cardiovasc Interv. 2021 Oct;98(4):713-720. doi: 10.1002/ccd.29329. Epub 2020 Oct 29. Catheter Cardiovasc Interv. 2021. PMID: 33118696 Free PMC article. Clinical Trial.
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy.
Tijssen RYG, Kerkmeijer LSM, Takahashi K, Kogame N, Katagiri Y, Kraak RP, Chichareon P, Modolo R, Asano T, Nassif M, Kalkman DN, Sotomi Y, Collet C, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Piek JJ, Tijssen JGP, Henriques JP, de Winter RJ, Onuma Y, Serruys PW, Wykrzykowska JJ. Tijssen RYG, et al. Among authors: arkenbout ek. Int J Cardiovasc Imaging. 2020 Apr;36(4):565-575. doi: 10.1007/s10554-019-01756-w. Epub 2020 Jan 2. Int J Cardiovasc Imaging. 2020. PMID: 31898006 Clinical Trial.
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
Kerkmeijer LSM, Tijssen RYG, Hofma SH, Pinxterhuis TH, Kraak RP, Kalkman DN, van der Schaaf RJ, Arkenbout EK, Weevers APJD, Beijk MA, Baan J Jr, Vis MM, Koch KT, Tijssen JGP, Piek JJ, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Kerkmeijer LSM, et al. Among authors: arkenbout ek. Int J Cardiol. 2020 Feb 1;300:93-98. doi: 10.1016/j.ijcard.2019.08.045. Epub 2019 Aug 30. Int J Cardiol. 2020. PMID: 31511193 Free article. Clinical Trial.
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial.
Kraak RP, Tijssen RYG, van Dongen IM, Elias J, Hofma SH, van der Schaaf RJ, Arkenbout EK, Weevers A, Tijssen JGP, Piek JJ, de Winter RJ, Henriques JPS, Wykrzykowska JJ; Collaborators. Kraak RP, et al. Among authors: arkenbout ek. EuroIntervention. 2020 Dec 4;16(11):e904-e912. doi: 10.4244/EIJ-D-18-00884. EuroIntervention. 2020. PMID: 31062692 Free article.
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
Tijssen RYG, van der Schaaf RJ, Kraak RP, Vink MA, Hofma SH, Arkenbout EK, Weevers APJD, Kerkmeijer LSM, Onuma Y, Serruys PW, Beijk MAM, Koch KT, Baan J Jr, Vis MM, Piek JJ, Tijssen JGP, Henriques JPS, de Winter RJ, Wykrzykowska JJ. Tijssen RYG, et al. Among authors: arkenbout ek. Catheter Cardiovasc Interv. 2020 Jan;95(1):89-96. doi: 10.1002/ccd.28193. Epub 2019 Apr 9. Catheter Cardiovasc Interv. 2020. PMID: 30968559 Clinical Trial.
37 results